Mesalamine dose may lower marker of bowel inflammation

Edward V. Loftus Jr., M.D., discusses an article looking at the ability of a drug to drive down calprotectin, a marker of bowel inflammation, in people who have ulcerative colitis.

Grand Rounds (CME): Bedside to Bench to Bedside: Individualizing Diagnosis and Therapy for Irritable Bowel Syndrome (IBS)

Arthur Beyder, M.D., Ph.D. and Gianrico Farrugia, M.D. present Bedside to Bench to Bedside: Individualizing Diagnosis and Therapy for Irritable Bowel Syndrome (IBS).

Grand Rounds (CME): Weighing Benefits and Risks: Role of Shared Decision Making in Type 2 Diabetes

Sonal Singh, M.D., M.P.H., presents Weighing Benefits and Risks: Role of Shared Decision Making in Type 2 Diabetes.

Grand Rounds — Tales From the Frozen Wasteland: The Epidemiology and Natural History of Crohn's Disease and Ulcerative Colitis in Olmsted County

Edward V. Loftus Jr., M.D., presents Tales From the Frozen Wasteland: The Epidemiology and Natural History of Crohn's Disease and Ulcerative Colitis in Olmsted County.

Grand Rounds: Individualizing Diagnosis and Therapy for IBS

Arthur Beyder, M.D., Ph.D., and Gianrico Farrugia, M.D., discuss the morbidity, pathophysiology and genetics of irritable bowel syndrome (IBS), a complex genetic disease.

Fecal microbiota transplantation (FMT)

Mayo Clinic's Robert Orenstein, D.O., and John K. DiBaise, M.D., explain and demonstrate the FMT procedures and techniques.